Plain-English translation of NCT07625748 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a device called transcranial temporal interference stimulation (tTIS) in children with autism spectrum disorder. The device uses gentle electrical stimulation applied to the scalp to target a specific brain region involved in social communication. Researchers want to see if this treatment is safe and feasible for children, and whether it might help improve social skills and communication.
Many children with autism struggle with social communication and interaction, and current treatments have limited effectiveness. This trial explores whether a new brain stimulation approach might offer a helpful option for these core challenges of autism.
You likely qualify if…
You likely don't qualify if…
Your child would first complete baseline assessments including intelligence testing, autism symptom scales, brain imaging, and an EEG recording. Then your child would be randomly assigned to receive either the active brain stimulation or a control stimulation for 5 days, with 6 treatment sessions per day lasting 20 minutes each. After treatment ends, you would return for follow-up visits over the next 4 weeks to monitor symptoms, safety, and any side effects.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
China